Corporate commitment to environmental sustainability in optical manufacturing is on the rise, and it’s having a trickle-down effect to greener thinking at the practice level. Insight looks at how the optical sector is taking steps to reduce its footprint. Read more
Current EyeQ Optometrists chief business development officer Ms Lily Wegrzynowski will transition into a new role as general manager eyecare & professional services as part of the company’s alliance with National Optical Care (NOC). Read more
The Turkish Competition Authority has cleared EssilorLuxottica’s GrandVision takeover. It’s the final country to approve the deal, but it won’t be finalised until arbitration proceedings are ironed out between the two companies. Read more
Eyetelligence is a new Australian-developed AI system helping clinicians screen for three types of eye disease. PROFESSOR MING HE – the clinical expert behind the software – discusses why optometrists should embrace the technology and its potential in other health fields.
Global eyewear giant Safilo is continuing to press ahead with its sustainability agenda with the introduction of electronic invoicing in Australia and the launch of a new sun lens material. Read more
Zeiss has announced former managing director of Carl Zeiss Vision South Africa Ms Gail Giordani will head its vision care business in Australia and New Zealand, taking over from Ms Hilke Fitzsimons. Read more
National Optical Care has arrived by acquiring 14 practices and launching a new buying group and managed services division. CEO MR JASON GOWIE explains the company’s ambitions for the eyecare sector and how it plans to make a positive impact. Read more
Specsavers has reportedly entered the North American market with the acquisition of a Canadian business with 18 practices. Read more
The Vision Eye Institute (VEI) has opened a new clinic on the New South Wales Central Coast, taking its total network to 28 practices. Read more
Glaukos has signed a new license agreement with Santen Pharmaceutical for the Preserflo MicroShunt, obtaining exclusive rights for the therapy in Australia, New Zealand and other territories. Read more